{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 470602455
| IUPAC_name = 4,4'-<nowiki/>{1,4-Phenylenebis[(''E'')methylylidene<br />(''E'')azanylylidene]}bis(1,2-oxazolidin-3-one)
| image = Terizidone.svg
| width = 275

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|terizidone}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =  C
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 25683-71-0
| ATC_prefix = J04
| ATC_suffix = AK03
| PubChem = 65720
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 59144
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 1199LEX5N8
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07247

<!--Chemical data-->
| C=14 | H=14 | N=4 | O=4 
| molecular_weight = 302.286 g/mol
| smiles = O=C3NOCC3/N=C/c2ccc(/C=N/C1C(=O)NOC1)cc2
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C14H14N4O4/c19-13-11(7-21-17-13)15-5-9-1-2-10(4-3-9)6-16-12-8-22-18-14(12)20/h1-6,11-12H,7-8H2,(H,17,19)(H,18,20)/b15-5+,16-6+
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = ODKYYBOHSVLGNU-IAGONARPSA-N
| synonyms = <small>4-[({4-[''N''-(3-oxo-1,2-oxazolidin-4-yl)carboximidoyl]phenyl}methylidene)amino]-1,2-oxazolidin-3-one</small>
}}

'''Terizidone''' is a drug used in the treatment of [[tuberculosis]].<ref>{{cite journal | pmid = 1922892 | volume=82 | issue=7-8 | title=[Tolerability to terizidone (TZ) in the treatment of pulmonary tuberculosis in dialyzed patients] | year=1991 | journal=Minerva Med. | pages=477â€“81}}</ref> Terizidone is used mainly used in [[multi-drug-resistant tuberculosis]] (MDR-TB) in conjunction with other second-line drugs. It is a derivate of [[cycloserine]] and it is bacteriostatic.<ref>{{Cite book|title = South African Medicines Formulary|last = Rossiter|first = Dawn|publisher = Health and Medical Publishing Group of the South African Medical Association|year = 2012|isbn = 978-1-875098-28-6|location = Cape Town, South Africa|pages = 323-325}}</ref>

==References==
{{reflist}}

{{Antimycobacterials}}

[[Category:Imines]]
[[Category:Isoxazolidinones]]
[[Category:Anti-tuberculosis drugs]]

{{antiinfective-drug-stub}}